<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-95820</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">What is happening with antiobesity drugs?</dc:title>
<dc:creator>Tinahones, Francisco José</dc:creator>
<dc:language>es</dc:language>
<dc:source>Endocrinol Nutr;58(3): 101-103, mar. 2011.</dc:source>
<dc:identifier>ibc-95820</dc:identifier>
<dc:title xml:lang="es">¿Qué está pasando con los fármacos para el tratamiento de la obesidad?</dc:title>
<dc:subject>^d9951^s22057</dc:subject>
<dc:subject>^d14885</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28460</dc:subject>
<dc:subject>^d33085^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201103</dc:date>
</metadata>
</record>
</ibecs-document>
